Rho, a full-service CRO, has added a new Regulatory Strategy and Submissions business segment to support the planning, development and submission of marketing applications, including new drug applications (NDAs), biological license applications (BLAs) and marketing authorization applications (MAAs).    Rob Woolson, MS, JD, an applied statistician with an extensive background in statistical and project leadership working on US and ex-US regulatory submissions, will lead the new segment as the C...